APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease

Human Molecular Genetics

Volumn 22, Issue 17, 2013, Pages 3460-3476

  Barbero Camps, Elisabet ^a,b   Fernández, Anna ^a,b   Martínez, Laura ^a,b   Fernández Checa, Jose C ^a,b,c   Colell, Anna ^a,b  

^a INST D INVESTIGACIONS B   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; GLUTATHIONE; GLUTATHIONE ETHYL ESTER; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SYNAPTOPHYSIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN LEVEL; BRAIN MITOCHONDRION; CHOLESTEROL HOMEOSTASIS; CONTROLLED STUDY; DEPLETION; ENZYME ACTIVATION; HOMEOSTASIS; MALE; MEMORY DISORDER; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPATIAL MEMORY; SYNAPTIC DEGENERATION; SYNAPTOTOXICITY; TRANSGENIC MOUSE;

EID: 84881592640     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt201     Document Type: Article

References (86)

1. Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., Troncoso, J.C. and Mattson, M.P. (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl Acad. Sci. USA, 101, 2070-2075.
2. Bandaru, V.V., Troncoso, J., Wheeler, D., Pletnikova, O., Wang, J., Conant, K., Haughey, N.J. (2009) ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiol. Aging, 30, 591-599.
3. Xiong, H., Callaghan, D., Jones, A., Walker, D.G., Lue, L.F., Beach, T.G., Sue, L.I., Woulfe, J., Xu, H., Stanimirovic, D.B. et al. (2008) Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol. Dis., 29, 422-437.
4. Panchal, M., Loeper, J., Cossec, J.C., Perruchini, C., Lazar, A., Pompon, D., Duyckaerts, C. (2010) Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry. J. Lipid Res., 51, 598-605.
5. Fernandez, A., Llacuna, L., Fernandez-Checa, J.C., Colell, A. (2009) Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J. Neurosci., 29, 6394-6405.
6. Pfrieger, F.W. (2003) Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol. Life Sci., 60, 1158-1171.
7. Shepardson, N.E., Shankar, G.M., Selkoe, D.J. (2011) Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch. Neurol., 68, 1239-1244.
8. Ehehalt, R., Keller, P., Haass, C., Thiele, C., Simons, K. (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol., 160, 113-123.
9. Kalvodova, L.,Kahya,N., Schwille, P., Ehehalt,R.,Verkade, P., Drechsel,D., Simons, K. (2005) Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem., 280, 36815-36823.
10. Osenkowski, P., Ye, W., Wang, R., Wolfe, M.S., Selkoe, D.J. (2008) Direct and potent regulation of gamma-secretase by its lipid microenvironment. J. Biol. Chem., 283, 22529-22540.
11. Yip, C.M., Elton, E.A., Darabie, A.A., Morrison, M.R., McLaurin, J. (2001) Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J. Mol. Biol., 311, 723-734.
12. Lee, C.Y., Tse, W., Smith, J.D., Landreth, G.E. (2012) Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem., 287, 2032-2044.
13. Grimm, M.O., Grimm, H.S., Patzold, A.J., Zinser, E.G., Halonen, R., Duering, M., Tschape, J.A.,De Strooper, B., Muller, U., Shen, J., et al. (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell Biol., 7, 1118-1123.
14. Liu, Q., Zerbinatti, C.V., Zhang, J., Hoe, H.S., Wang, B., Cole, S.L., Herz, J., Muglia, L., Bu, G. (2007) Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron, 56, 66-78.
15. Bryleva,E.Y.,Rogers,M.A.,Chang,C.C.,Buen,F.,Harris, B.T.,Rousselet,E., Seidah, N.G., Oddo, S., LaFerla, F.M., Spencer, T.A., et al. (2010) ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proc. Natl Acad. Sci. USA, 107, 3081-3086.
16. Yao, J., Ho, D., Calingasan, N.Y., Pipalia, N.H., Lin, M.T., Beal, M.F. (2012) Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. J. Exp. Med., 209, 2501-2513.
17. Colell, A., Fernandez, A., Fernandez-Checa, J.C. (2009) Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease. J. Bioenerg. Biomembr., 41, 417-423.
18. Ashe, K.H., Zahs, K.R. (2010) Probing the biology of Alzheimer's disease in mice. Neuron, 66, 631-645.
19. Chabrier, M.A., Blurton-Jones, M., Agazaryan, A.A., Nerhus, J.L., Martinez-Coria, H., LaFerla, F.M. (2012) Soluble abeta promotes wild-type tau pathology in vivo. J. Neurosci., 32, 17345-17350.
20. Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., Selkoe, D.J. (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl Acad. Sci. USA, 108, 5819-5824.
21. Tokutake, T., Kasuga, K., Yajima, R., Sekine, Y., Tezuka, T., Nishizawa, M., Ikeuchi, T. (2012) Hyperphosphorylation of Tau induced by naturally secreted amyloid-beta at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3beta signaling pathway. J. Biol. Chem., 287, 35222-35233.
22. Melov, S., Adlard, P.A., Morten, K., Johnson, F., Golden, T.R., Hinerfeld, D., Schilling, B., Mavros, C., Masters, C.L., Volitakis, I., et al. (2007) Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One, 2, e536.
23. Iijima-Ando, K., Sekiya, M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B., Iijima, K.M. (2012) Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1. PLoS Genet, 8, e1002918.
24. DuBoff, B., Gotz, J., Feany, M.B. (2012) Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron, 75, 618-632.
25. Distl, R., Meske, V., Ohm, T.G. (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol., 101, 547-554.
26. Love, S., Bridges, L.R., Case, C.P. (1995) Neurofibrillary tangles in Niemann-Pick disease type C. Brain, 118 (Pt 1), 119-129.
27. Yu, W., Gong, J.S., Ko, M., Garver, W.S., Yanagisawa, K., Michikawa, M. (2005) Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J. Biol. Chem., 280, 11731-11739.
28. Sawamura, N., Gong, J.S., Garver, W.S., Heidenreich, R.A., Ninomiya, H., Ohno, K., Yanagisawa, K., Michikawa, M. (2001) Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice. J. Biol. Chem., 276, 10314-10319.
29. Burns, M., Gaynor, K., Olm, V., Mercken, M., LaFrancois, J., Wang, L., Mathews, P.M., Noble, W., Matsuoka, Y., Duff, K. (2003) Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. J. Neurosci., 23, 5645-5649.
30. Kodam, A., Maulik, M., Peake, K., Amritraj, A., Vetrivel, K.S., Thinakaran, G., Vance, J.E., Kar, S. (2010) Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains. Glia, 58, 1267-1281.
31. Maulik, M., Ghoshal, B., Kim, J., Wang, Y., Yang, J., Westaway, D., Kar, S. (2012) Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a beta-cyclodextrin. Hum. Mol. Genet., 21, 4857- 4875.
32. Glockner, F., Meske, V., Lutjohann, D., Ohm, T.G. (2011) Dietary cholesterol and its effect on tau protein: a study in apolipoprotein E-deficient and P301L human tau mice. J. Neuropathol. Exp. Neurol., 70, 292-301.
33. Rahman, A., Akterin, S., Flores-Morales, A., Crisby, M., Kivipelto, M., Schultzberg, M., Cedazo-Minguez, A. (2005) High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice. FEBS Lett., 579, 6411-6416.
34. Games, D., Buttini, M., Kobayashi, D., Schenk, D., Seubert, P. (2006) Mice as models: transgenic approaches and Alzheimer's disease. J. Alzheimers Dis., 9, 133-149.
35. Yang, D.S., Kumar, A., Stavrides, P., Peterson, J., Peterhoff, C.M., Pawlik, M., Levy, E., Cataldo, A.M., Nixon, R.A. (2008) Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. Am. J. Pathol., 173, 665-681.
36. Sadowski, M., Pankiewicz, J., Scholtzova, H., Ji, Y., Quartermain, D., Jensen, C.H., Duff, K., Nixon, R.A., Gruen, R.J., Wisniewski, T. (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. J. Neuropathol. Exp. Neurol., 63, 418-428.
37. Brown, M.W., Aggleton, J.P. (2001) Recognition memory: what are the roles of the perirhinal cortex and hippocampus. Nat. Rev. Neurosci., 2, 51-61.
38. Winters, B.D., Forwood, S.E., Cowell, R.A., Saksida, L.M., Bussey, T.J. (2004) Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe. J. Neurosci., 24, 5901- 5908. 39. Mattsson, N., Olsson, M., Gustavsson, M.K., Kosicek, M., Malnar, M., Mansson, J.E., Blomqvist, M., Gobom, J., Andreasson, U., Brinkmalm, G., et al. (2012) Amyloid-beta metabolism in Niemann-Pick C disease models and patients. Metab. Brain Dis., 27, 573-585.
39. Mattsson, N., Olsson, M., Gustavsson, M.K., Kosicek, M., Malnar, M., Mansson, J.E., Blomqvist, M., Gobom, J., Andreasson, U., Brinkmalm, G., et al. (2012) Amyloid-beta metabolism in Niemann-Pick C disease models and patients. Metab. Brain Dis., 27, 573-585.
40. Nishimura, M., Tomimoto, H., Suenaga, T., Namba, Y., Ikeda, K., Akiguchi, I., Kimura, J. (1995) Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. Am. J. Pathol., 146, 1052- 1058.
41. Rudrabhatla, P., Pant, H.C. (2011) Role of protein phosphatase 2A in Alzheimer's disease. Curr. Alzheimer Res., 8, 623-632.
42. Wang, Y.P., Biernat, J., Pickhardt, M., Mandelkow, E., Mandelkow, E.M. (2007) Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc. Natl Acad. Sci. USA, 104, 10252-10257.
43. Nicholson, A.M., Ferreira, A. (2009) Increased membrane cholesterol might render mature hippocampal neurons more susceptible to beta-amyloid-induced calpain activation and tau toxicity. J. Neurosci., 29, 4640-4651.
44. Ma, T., Zhao, Y., Kwak, Y.D., Yang, Z., Thompson, R., Luo, Z., Xu, H., Liao, F.F. (2009) Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. J. Neurosci., 29, 11226-11236.
45. Chen, X., Wagener, J.F., Morgan, D.H., Hui, L., Ghribi, O., Geiger, J.D. (2010) Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet. J. Alzheimers Dis., 22, 1289-1303.
46. Ray, P.D., Huang, B.W., Tsuji, Y. (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal, 24, 981- 990.
47. Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., Cole, G.M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci., 21, 8370-8377.
48. Li, F., Calingasan, N.Y., Yu, F., Mauck, W.M., Toidze, M., Almeida, C.G., Takahashi, R.H., Carlson, G.A., Flint Beal, M., Lin, M.T., et al. (2004) Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem., 89, 1308-1312.
49. Dumont, M., Wille, E., Stack, C., Calingasan, N.Y., Beal, M.F., Lin, M.T. (2009) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J., 23, 2459-2466.
50. Mari, M., Morales, A., Colell, A., Garcia-Ruiz, C., Fernandez-Checa, J.C. (2009) Mitochondrial glutathione, a key survival antioxidant. Antioxid. Redox Signal., 11, 2685-2700.
51. Merkwirth, C., Martinelli, P., Korwitz, A., Morbin, M., Bronneke, H.S., Jordan, S.D., Rugarli, E.I., Langer, T. (2012) Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration. PLoS Genet, 8, e1003021.
52. Giannakopoulos, P., Herrmann, F.R., Bussiere, T., Bouras, C., Kovari, E., Perl, D.P., Morrison, J.H., Gold, G., Hof, P.R. (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology, 60, 1495-1500.
53. Nagy, Z., Esiri, M.M., Jobst, K.A., Morris, J.H., King, E.M., McDonald, B., Litchfield, S., Smith, A., Barnetson, L., Smith, A.D. (1995) Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia, 6, 21-31.
54. Mocanu, M.M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., Petrova, O., Schonig, K., Bujard, H., Mandelkow, E., et al. (2008) The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci., 28, 737-748.
55. Van der Jeugd, A., Hochgrafe, K., Ahmed, T., Decker, J.M., Sydow, A., Hofmann, A., Wu, D., Messing, L., Balschun, D., D'Hooge, R., et al. (2012) Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathol., 123, 787-805.
56. Duyckaerts, C., Potier, M.C., Delatour, B. (2008) Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol., 115, 5-38.
57. Distl, R., Treiber-Held, S., Albert, F., Meske, V., Harzer, K., Ohm, T.G. (2003) Cholesterol storage and tau pathology in Niemann-Pick type C disease in the brain. J. Pathol., 200, 104-111.
58. Auer, I.A., Schmidt, M.L., Lee, V.M., Curry, B., Suzuki, K., Shin, R.W., Pentchev, P.G., Carstea, E.D., Trojanowski, J.Q. (1995) Paired helical filament tau (PHFtau) in Niemann-Pick typeCdisease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol., 90, 547-551.
59. Bu, B., Li, J., Davies, P., Vincent, I. (2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci., 22, 6515-6525.
60. Liu, B., Turley, S.D., Burns, D.K., Miller, A.M., Repa, J.J., Dietschy, J.M. (2009) Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc. Natl Acad. Sci. USA, 106, 2377-2382.
61. Davidson, C.D., Ali, N.F., Micsenyi, M.C., Stephney, G., Renault, S., Dobrenis, K., Ory, D.S., Vanier, M.T., Walkley, S.U. (2009) Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One, 4, e6951.
62. Kowall, N.W., Kosik, K.S. (1987) Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease. Ann. Neurol., 22, 639-643.
63. Delacourte, A., Flament, S., Dibe, E.M., Hublau, P., Sablonniere, B., Hemon,B., Sherrer, V., Defossez, A. (1990) Pathological proteinsTau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol., 80, 111-117.
64. Cowan, C.M., Quraishe, S., Mudher, A. (2012) What is the pathological significance of tau oligomers? Biochem. Soc. Trans., 40, 693-697.
65. Bolmont, T., Clavaguera, F., Meyer-Luehmann, M., Herzig, M.C., Radde, R., Staufenbiel, M., Lewis, J., Hutton, M., Tolnay, M., Jucker, M. (2007) Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am. J. Pathol., 171, 2012-2020.
66. Zempel, H., Thies, E., Mandelkow, E., Mandelkow, E.M. (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci., 30, 11938-11950.
67. Hernandez, P., Lee, G., Sjoberg, M., Maccioni, R.B. (2009) Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts. J. Alzheimers Dis., 16, 149-156.
68. Schenck, A., Goto-Silva, L., Collinet, C., Rhinn, M., Giner, A., Habermann, B., Brand, M., Zerial, M. (2008) The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell, 133, 486-497.
69. Garcia-Ruiz, C., Mari, M., Colell, A., Morales, A., Caballero, F., Montero, J., Terrones, O., Basanez, G., Fernandez-Checa, J.C. (2009) Mitochondrial cholesterol in health and disease. Histol. Histopathol., 24, 117-132.
70. Garcia-Ruiz, C., Morales, A., Fernandez-Checa, J.C. (2012) Statins and protein prenylation in cancer cell biology and therapy. Anticancer Agents Med. Chem., 12, 303-315.
71. Eckert, G.P., Hooff, G.P., Strandjord, D.M., Igbavboa, U., Volmer, D.A., Muller, W.E., Wood, W.G. (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol. Dis., 35, 251-257.
72. Hamano, T., Yen, S.H., Gendron, T., Ko, L.W., Kuriyama, M. (2012) Pitavastatin decreases tau levels via the inactivation of Rho/ROCK. Neurobiol. Aging, 33, 2306-2320.
73. Boimel, M., Grigoriadis, N., Lourbopoulos, A., Touloumi, O., Rosenmann, D., Abramsky, O., Rosenmann, H. (2009) Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J. Neuropathol. Exp. Neurol., 68, 314-325.
74. Shankar, G.M., Li, S., Mehta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett, F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A., et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med., 14, 837-842.
75. Braak, H., Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol., 82, 239-259.
76. Juottonen, K., Laakso, M.P., Insausti, R., Lehtovirta, M., Pitkanen, A., Partanen, K., Soininen, H. (1998) Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol. Aging, 19, 15-22.
77. Delacourte, A., David, J.P., Sergeant, N., Buee, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology, 52, 1158-1165.
78. Clausen, A., Xu, X., Bi, X., Baudry, M. (2012) Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. J. Alzheimers Dis., 30, 183-208.
79. McManus, M.J., Murphy, M.P., Franklin, J.L. (2011) The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J. Neurosci., 31, 15703-15715.
80. von Montfort, C., Matias, N., Fernandez, A., Fucho, R., Conde de la Rosa, L., Martinez-Chantar, M.L., Mato, J.M., Machida, K., Tsukamoto, H., Murphy, M.P., et al. (2012) Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J. Hepatol., 57, 852-859.
81. Tietze, F. (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem., 27, 502-522.
82. Duncan, I.W., Culbreth, P.H., Burtis, C.A. (1979) Determination of free, total, and esterified cholesterol by high-performance liquid chromatography. J. Chromatogr., 162, 281-292.
83. Greenberg, S.G., Davies, P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl Acad. Sci. USA, 87, 5827-5831.
84. Schmued, L.C., Albertson, C., Slikker, W. Jr (1997) Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res., 751, 37-46.
85. Morris, R. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods, 11, 47-60.
86. Bevins, R.A., Besheer, J. (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat. Protoc., 1, 1306-1311.